CGTX Cognition Therapeutics, Inc.
$0.75▼ -1.33%
Healthcare
Other
After hours
$0.74▼ -1.87%
Oct 28, 4:03 PM ET
Volume 350.9K
Avg Volume (10D) 516.5K
Key Metrics & Fundamentals
Market Cap
$71.23M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.55 - 1.83
% vs 50 MA
-18.90%
% vs 200 MA
-30.25%
RSI-14
37.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.77
Free Cash Flow
-$3.07M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.87M
COGS
–
Operating Exp
$4.22M
Operating Income
-$4.22M
EBIT
-$4.22M
Pretax Income
-$3.93M
Net Income
-$3.93M
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
GlobeNewswire · Oct 22, 2026 6:00 AM ET
Cognition Therapeutics Secures US Patent for Zervimesine Through 2045 Ahead of Planned Phase 3 Development
InvestorsHub · Oct 13, 2026 6:59 AM ET
Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045
GlobeNewswire · Oct 13, 2026 6:00 AM ET
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
GlobeNewswire · Sep 29, 2026 7:30 AM ET
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
GlobeNewswire · Sep 8, 2026 7:30 AM ET
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 7:10 PM ET
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
GlobeNewswire · Aug 6, 2026 4:15 PM ET
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
GlobeNewswire · Aug 6, 2026 4:15 PM ET
Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
PR Newswire · Aug 3, 2026 10:31 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CGTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.